TranS1 (TSON)
TranS1 Market Cap: 81.48M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
TSON Market Cap Rankings
| Overall | 21st percentile | 3678 of 4664 |
| Sector | 27th percentile | 381 of 527 in Healthcare |
| Industry | 28th percentile | 49 of 69 in Medical Instruments & Supplies |
TSON Market Cap Range, Past 5 Years
| Minimum | 41.32M | Dec 2010 |
| Maximum | 325.78M | Dec 2007 |
| Average | 124.05M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these TSON related companies
TSON News
TranS1 Inc. Announces Participation in Two Investor Conferences in June 2012
May 30, 4:30PM GlobeNewswire
May 30, 4:30PM GlobeNewswire
TranS1 Inc. Reports Operating Results for the First Quarter of 2012, Issues Second Quarter 2012 Guidance
May 08, 4:01PM GlobeNewswire
May 08, 4:01PM GlobeNewswire
$TSON forms bearish "Top Triangle" chart pattern. http://stks.co/3fNV
about 28 days ago by RecogniaEvents
about 28 days ago by RecogniaEvents
TranS1 Inc. to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
May 02, 7:30AM GlobeNewswire
May 02, 7:30AM GlobeNewswire
$TSON filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3ab7
about 32 days ago by MarketBrief
about 32 days ago by MarketBrief
TranS1 Inc. Schedules First Quarter 2012 Results Conference Call for Tuesday, May 8, 2012
Apr 25, 4:01PM GlobeNewswire
Apr 25, 4:01PM GlobeNewswire
$TSON forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/3LWv
about 48 days ago by RecogniaEvents
about 48 days ago by RecogniaEvents
Pomerantz Law Firm Reminds Shareholders of TranS1 of Upcoming Deadline - TSON
Mar 16, 10:22AM GlobeNewswire
Mar 16, 10:22AM GlobeNewswire
Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against TranS1 Inc.
Mar 10, 6:00AM Business Wire
Mar 10, 6:00AM Business Wire
Canaccord Genuity maintains a 'Buy' on TranS1 Inc (TSON); View 2012 as Transitional Year After Weak Qtr
Mar 09, 10:13AM Street Insider
Mar 09, 10:13AM Street Insider
TranS1 Inc. Reports Operating Results for the Fourth Quarter of 2011, Issues First Quarter 2012 Guidance
Mar 08, 4:01PM GlobeNewswire
Mar 08, 4:01PM GlobeNewswire
Canaccord Genuity Reiterates a 'Buy' TranS1 Inc (TSON); Positive AMA Coding Panel Decision; Level I Code Imminent
Mar 05, 9:56AM Street Insider
Mar 05, 9:56AM Street Insider
Trans1 (TSON) Ramps Higher Following AMA CPT Approval of AxiaLIF for Cat I Code
Mar 05, 9:45AM Street Insider
Mar 05, 9:45AM Street Insider
TranS1 (TSON) Gets Approval from AMA CPT for AxiaLIF Implant in L5-S1 Spinal Fusion
Mar 05, 7:35AM Street Insider
Mar 05, 7:35AM Street Insider
Pomerantz Law Firm Reminds Shareholders of TranS1 of Upcoming Deadline - TSON
Mar 02, 4:12PM GlobeNewswire
Mar 02, 4:12PM GlobeNewswire
UPDATE - Canaccord Genuity Upgraded TranS1 Inc (TSON) to Buy; Reimbursement Gaining Momentum
Feb 27, 8:17AM Street Insider
Feb 27, 8:17AM Street Insider
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against TranS1 Inc.
Feb 25, 6:00AM Business Wire
Feb 25, 6:00AM Business Wire
TranS1 Inc. Schedules Fourth Quarter 2011 Results Conference Call for Thursday, March 8, 2012
Feb 23, 9:00AM GlobeNewswire
Feb 23, 9:00AM GlobeNewswire
Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against TranS1, Inc.
Feb 18, 10:56PM Business Wire
Feb 18, 10:56PM Business Wire
Pomerantz Law Firm Reminds Shareholders of TranS1 of Upcoming Deadline -- TSON
Feb 17, 3:33PM GlobeNewswire
Feb 17, 3:33PM GlobeNewswire
TranS1 Inc. to Participate in the Lazard Capital Markets 4rd Annual Medical Technology Snowbird Event
Feb 16, 7:30AM GlobeNewswire
Feb 16, 7:30AM GlobeNewswire
Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against TranS1 Inc.
Feb 06, 8:00PM Business Wire
Feb 06, 8:00PM Business Wire
Pomerantz Law Firm Reminds Shareholders of TranS1 of Upcoming Deadline - TSON
Feb 03, 4:53PM GlobeNewswire
Feb 03, 4:53PM GlobeNewswire
Canaccord Genuity Maintains a 'Hold' on TranS1 Inc (TSON); Securing Incremental Payers is Positive, but Not a Home-run
Jan 30, 9:41AM Street Insider
Jan 30, 9:41AM Street Insider
$TSON http://stks.co/24dR Got extreme outside the bands w/ Bullish MACD divgergence. Put in base & is on the move.
about 128 days ago by Fibline
about 128 days ago by Fibline
is $TSON a cup and handle set up? before this breakout, anybody see that pattern or I am mad? thanks folks
about 170 days ago by ignaciomas
about 170 days ago by ignaciomas
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TSON | 2.93 | -0.05 | -1.68% | 81.20M |
| TSO | 22.12 | -1.09 | -4.70% | 3.265B |
| TSM | 13.73 | -0.20 | -1.44% | 72.20B |
| TNB | 71.99 | +0.00 | +0.00% | 3.758B |
| TNAV | 6.01 | +0.20 | +3.44% | 241.81M |
| TNA | 47.26 | -0.31 | -0.65% | |
| TMX | 15.33 | +0.00 | +0.00% | |
| TMS | 11.10 | -0.37 | -3.23% | |
| TMP | 36.61 | +0.01 | +0.03% | 408.46M |
| TIVO | 8.54 | -0.42 | -4.69% | 1.044B |
